Clinical trials sponsored by Luye Pharma Group Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Luye Pharma Group Ltd.

• A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
  NCT07230652 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
  NCT06496048 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer
  NCT06128837 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Luye Pharma Group Ltd. recruiting for?

Luye Pharma Group Ltd. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.